(Q36927536)

17 August 2017

1 reference

title

Biologic effects of nerve growth factor on lesioned basal forebrain neurons (English)

1 reference

17 August 2017

Biologic Effects of Nerve Growth Factor on Lesioned Basal Forebrain Neuronsa (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

history and philosophy of science

21 November 2022

main subject

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

21 November 2022

author

Richard E Clatterbuck

2

object named as

Clatterbuck RE

1 reference

17 August 2017

V. E. Koliatsos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776727

21 November 2022

G. K. Gouras

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776727

21 November 2022

D. L. Price

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776727

21 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

full work available at URL

17 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1991.tb00199.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1991.tb00199.x/fullpdf

21 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Annals of the New York Academy of Sciences

21 November 2022

published in

1 reference

17 August 2017

640

1 reference

17 August 2017

102-109

1 reference

Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Response of septal cholinergic neurons to axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Neurotrophic factor for central cholinergic neurones is present in both normal and Alzheimer brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Developmental cell death: morphological diversity and multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Morphological response of axotomized septal neurons to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

NGF effects on developing forebrain cholinergic neurons are regionally specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

A novel group of nerve growth factor receptor-immunoreactive neurons in the ventral horn of the lumbar spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Nerve growth factor treatment after brain injury prevents neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Potential use of nerve growth factor to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

New perspectives on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Basal forebrain neurons in the dementia of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00199.X

Expression of the beta-nerve growth factor gene in hippocampal neurons

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

NGF-Mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain?

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease.

21 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons

21 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Nerve growth factor and Alzheimer's disease

21 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Diagnosis of Alzheimer's disease

21 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Aberrant phosphorylation of neurofilaments accompanies transmitter-related changes in rat septal neurons following transection of the fimbria-fornix

21 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey.

21 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Taxol produces a predominantly sensory neuropathy

21 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons

21 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Expression of NGF receptor in the developing and adult primate central nervous system

21 November 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Senile plaques in aged squirrel monkeys

21 November 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

Neurotoxic effects of cisplatin therapy

21 November 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00199.X

21 November 2022

Identifiers

1 reference

17 August 2017

1 reference